We analyzed the dataset from TCGA and concluded that the expression of SOX12 in breast cancer tissues was higher than that in normal tissues (Figure 5C), which was further verified by the RT-qPCR analysis and Western blot assay in clinical samples (Figures 5D, E). This evidence concerns the gene SOX12 and breast cancer.